TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25407798

Group type: EXPERIMENTAL
Intervention: Aleglitazar 150 μg/day
Number of subjects: 302

Group type: COMPARATOR
Intervention: Pioglitazone 45 mg/day
Number of subjects: 302
Study: 22420349

Group type: EXPERIMENTAL
Intervention: Life review therapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo condition with supportive therapy
Number of subjects: 37
Study: 20565430

Group type: EXPERIMENTAL
Intervention: Paliperidone ER (3-12 mg/day)
Number of subjects: 493
Study: 17563512

Group type: EXPERIMENTAL
Intervention: Immediate loading of mandibular bar-retained overdenture supported by 4 endosseous implants loaded immediately after implant placement.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Delayed loading of mandibular bar-retained overdenture supported by 4 endosseous implants that remained submerged for a period of 4 months before loading.
Number of subjects: 10
Study: 16159809

Group type: EXPERIMENTAL
Intervention: phVEGF-A165 (n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (n=40)
Number of subjects: 80
Study: 12182268

Group type: EXPERIMENTAL
Intervention: Cue exposure following a priming dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive-behavioral intervention
Number of subjects: 0
Study: 10067908

Group type: EXPERIMENTAL
Intervention: Vitamin E supplements
Number of subjects: 21120

Group type: EXPERIMENTAL
Intervention: Multivitamins
Number of subjects: 21120

Group type: EXPERIMENTAL
Intervention: Vitamin C supplements
Number of subjects: 21120
Study: 7640921

Group type: EXPERIMENTAL
Intervention: Diaphragmatic ultrasound (DUS)
Number of subjects: 30
Study: 2182978

Group type: EXPERIMENTAL
Intervention: Active management with i.v. Ergometrine 0.5 mg
Number of subjects: 1429

Group type: COMPARATOR
Intervention: Physiological management
Number of subjects: 1429

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1429
Study: 6797318

Group type: EXPERIMENTAL
Intervention: Subarachnoid block (SAB)
Number of subjects: 132

Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 132
Study: 31159750

Group type: COMPARATOR
Intervention: 3% saline with placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3% saline with furosemide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3% saline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Furosemide with 3% saline
Number of subjects: 0
Study: 28626886

Group type: EXPERIMENTAL
Intervention: Incorporating activities to promote youth thriving into mentoring relationships
Number of subjects: 806

Group type: COMPARATOR
Intervention: Standard services
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Positive engagement with thriving promotion activities
Number of subjects: 806
Study: 26012783

Group type: EXPERIMENTAL
Intervention: Facebook Group (social media delivery)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pamphlet Group (standard delivery)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control Group (usual care following Australian Dietary Guidelines)
Number of subjects: 120
Study: 23718565

Group type: EXPERIMENTAL
Intervention: Experimental group (multifaceted implementation strategy including website access, newsletters, telephone approaches, outreach visits for physicians and managers; postgraduate course, training days, outreach visits, regional meetings, reporting system for occupational therapists)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no interventions for physicians and managers; postgraduate course for occupational therapists)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Non-participating physicians' referrals in experimental clusters
Number of subjects: 45
Study: 22054619

Group type: EXPERIMENTAL
Intervention: Presence of primitive reflexes preoperatively
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Presence of two or more primitive reflexes postoperatively
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Presence of frontal release signs postoperatively
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Presence of three or more frontal release signs postoperatively
Number of subjects: 79
Study: 19462695

Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Geriatric Depression Scale (GDS)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Mini Mental State Examination
Number of subjects: 83
Study: 17971616

Group type: EXPERIMENTAL
Intervention: Aerobic training for 8 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no aerobic training)
Number of subjects: 64
Study: 15377842

Group type: EXPERIMENTAL
Intervention: Intravenous clodronate (1500 mg each, seven cycles)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (no further therapy)
Number of subjects: 45
Study: 11429351

Group type: EXPERIMENTAL
Intervention: Morphine 1 mg/mL plus ketamine 1 mg/mL (Group MK)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Morphine 1 mg/mL (Group M)
Number of subjects: 71
Study: 9701181

Group type: EXPERIMENTAL
Intervention: Red wine (375 mL/d)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: RWPP capsules (1 g/d)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: RWPPs in white wine (1 g/d)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: White wine (375 mL/d)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control alcoholic drink (40 g ethanol/d)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: RWPPs (1 g/d)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: RWPPs (2 g/d)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Vitamin E (1000 IU/d)
Number of subjects: 6
Study: 9390335

Group type: EXPERIMENTAL
Intervention: Tacalcitol ointment (4 micrograms/g) once daily
Number of subjects: 287

Group type: COMPARATOR
Intervention: Calcipotriol ointment (50 micrograms/g) twice daily
Number of subjects: 287
Study: 1759492

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine (PT‐9K/129G, FHA, 69 kDa)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7117678

Group type: EXPERIMENTAL
Intervention: Nabumetone (1 g at night) for 2 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Naproxen (250 mg b.i.d) for 2 weeks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Physician's assessment
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Side effects reported
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Drug preference
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Renal, hepatic or haematopoietic function
Number of subjects: 21
Study: 31605520

Group type: EXPERIMENTAL
Intervention: Caffeine chewing gum (CG)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeine dissolvable mouth strips (CS)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeine tablet (CT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 14
Study: 27507905

Group type: EXPERIMENTAL
Intervention: OC-Sensor (Eiken, Japan)
Number of subjects: 19291

Group type: COMPARATOR
Intervention: FOB-Gold (Sentinel, Italy)
Number of subjects: 19291

Group type: EXPERIMENTAL
Intervention: OC-Sensor
Number of subjects: 19291

Group type: COMPARATOR
Intervention: FOB-Gold
Number of subjects: 19291
Study: 27803090

Group type: EXPERIMENTAL
Intervention: PCI Choice Decision Aid (DA)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 124
Study: 25174846

Group type: COMPARATOR
Intervention: Traditional prosthesis group (n = 8)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Anatomical prosthesis group (n = 8)
Number of subjects: 16
Study: 21922186

Group type: EXPERIMENTAL
Intervention: FCR (Fludarabine, Cyclophosphamide, Rituximab)
Number of subjects: 184

Group type: COMPARATOR
Intervention: PCR (Pentostatin, Cyclophosphamide, Rituximab)
Number of subjects: 184
Study: 20570398

Group type: EXPERIMENTAL
Intervention: Changes in thickness of the banks of the inferior parietal lobule
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Changes in thickness of the gyrus and fundus of the inferior parietal lobule
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Neuropsychological performance measures
Number of subjects: 54
Study: 17968168

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training curriculum; 10 novice surgeons completed VR training followed by 3 porcine laparoscopic cholecystectomies each.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (traditional training); 10 control subjects performed 5 cadaveric porcine laparoscopic cholecystectomies each.
Number of subjects: 30
Study: 15868594

Group type: EXPERIMENTAL
Intervention: Lung radiotherapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Lung-only metastases
Number of subjects: 46

Group type: COMPARATOR
Intervention: Unilateral disease or fewer than 5 metastatic lesions
Number of subjects: 46

Group type: COMPARATOR
Intervention: Unfavorable histology
Number of subjects: 46

Group type: COMPARATOR
Intervention: Age >10 years
Number of subjects: 46
Study: 12522893

Group type: EXPERIMENTAL
Intervention: Irbesartan (150 mg once daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fosinopril (20 mg once daily)
Number of subjects: 30
Study: 9552287

Group type: EXPERIMENTAL
Intervention: High noise exposure
Number of subjects: 33

Group type: COMPARATOR
Intervention: Low noise exposure
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: High effort
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Low effort
Number of subjects: 33
Study: 8400769

Group type: EXPERIMENTAL
Intervention: Acupuncture (once or 7 times a week)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acupuncture (7 times a week)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Active acupuncture
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-acupuncture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acupuncture at non-acupoints (ANA)
Number of subjects: 40
Study: 3946804

Group type: EXPERIMENTAL
Intervention: Nalmefene 2 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nalmefene 1 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nalmefene 0.5 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 6
Study: 30340505

Group type: EXPERIMENTAL
Intervention: Ribociclib + letrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo + letrozole
Number of subjects: 0
Study: 27085566

Group type: EXPERIMENTAL
Intervention: Oximacro (36 mg PACs‐A) administered twice per day for 7 days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (no PACs)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Oximacro (36 mg PACs‐A)
Number of subjects: 70
Study: 24399428

Group type: EXPERIMENTAL
Intervention: Sertraline plus clonazepam (up to 3.0 mg/day)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Sertraline plus placebo
Number of subjects: 181

Group type: COMPARATOR
Intervention: Venlafaxine (up to 225 mg/day)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Overall response rate (LSAS score <50)
Number of subjects: 181
Study: 22516309

Group type: EXPERIMENTAL
Intervention: Four hygienic‐dietary recommendations
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 80
Study: 20167903

Group type: EXPERIMENTAL
Intervention: HIV/STD risk-reduction intervention
Number of subjects: 1707

Group type: COMPARATOR
Intervention: Health-promotion control intervention
Number of subjects: 1707
Study: 18417963

Group type: EXPERIMENTAL
Intervention: Danqi Piantan Jiaonang (DPJ) 4 capsules (0.4 g/capsule) taken orally 2 times 6 hours apart
Number of subjects: 42

Group type: COMPARATOR
Intervention: Combination of aspirin 300 mg and 2 doses of DPJ 4 capsules taken 6 hours apart
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Danqi Piantan Jiaonang (DPJ) 4 capsules taken orally 3 times a day for 1 month
Number of subjects: 42
Study: 15783004

Group type: EXPERIMENTAL
Intervention: Dai‐ken‐chu‐to and Keish‐bukuryo‐gan (7.5g and 6.0g respectively)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (no herbal medicine)
Number of subjects: 66
Study: 12431854

Group type: EXPERIMENTAL
Intervention: Progesterone (P4) replacement in women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estradiol (E2) replacement in women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testosterone (T) replacement in men
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypogonadism (leuprolide-induced)
Number of subjects: 0
Study: 10495595

Group type: EXPERIMENTAL
Intervention: Evidence-based interventions for improving care for depression
Number of subjects: 46
Study: 8739165

Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Augmentin
Number of subjects: 29
Study: 1299814

Group type: EXPERIMENTAL
Intervention: Amikacin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Netilmicin
Number of subjects: 30
Study: 6237085

Group type: EXPERIMENTAL
Intervention: Nitroimidazole radiosensitizers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sural nerve biopsies
Number of subjects: 0
Study: 30167807

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure treatment (< 120 mmHg) in the low-SBP group
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard systolic blood pressure treatment (< 140 mmHg) in the low-SBP group
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure treatment (< 120 mmHg) in the high-SBP group
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard systolic blood pressure treatment (< 140 mmHg) in the high-SBP group
Number of subjects: 9361
Study: 29961053

Group type: EXPERIMENTAL
Intervention: Flex 19G needle
Number of subjects: 78

Group type: COMPARATOR
Intervention: 22G needle
Number of subjects: 78
Study: 26894640

Group type: EXPERIMENTAL
Intervention: Suprapatellar (SP) tibial nail insertion
Number of subjects: 41

Group type: COMPARATOR
Intervention: Infrapatellar (IP) tibial nail insertion
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups (SP and IP)
Number of subjects: 41
Study: 25238874

Group type: EXPERIMENTAL
Intervention: Risk Instrument for Screening in the Community (RISC)
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Clinical Frailty Scale (CFS)
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Barthel Index
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Abbreviated Mental Test Score (AMTS)
Number of subjects: 803
Study: 22326435

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 20816187

Group type: EXPERIMENTAL
Intervention: Combination inhaler (125 microg fluticasone dipropionate and 25 microg salmeterol, 2 actuations twice daily)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Separate inhalers (125 microg fluticasone dipropionate and 25 microg salmeterol, 2 actuations twice daily)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Combination inhaler vs. fluticasone
Number of subjects: 111

Group type: COMPARATOR
Intervention: Combination inhaler vs. salmeterol
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: LABA monotherapy
Number of subjects: 111
Study: 18077927

Group type: EXPERIMENTAL
Intervention: Paroxetine oral solution (20 mg/20 drops)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Paroxetine tablets (20 mg)
Number of subjects: 48
Study: 15579724

Group type: EXPERIMENTAL
Intervention: Stable asthma
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Bronchiectasis
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Acute asthma exacerbation
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Asthma severity pattern
Number of subjects: 71

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 71
Study: 12087641

Group type: EXPERIMENTAL
Intervention: HeartPower! Program
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard health education curriculum
Number of subjects: 58
Study: 9796960

Group type: EXPERIMENTAL
Intervention: Intravenous mesna
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Oral mesna
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both i.v. and oral mesna
Number of subjects: 25
Study: 7607199

Group type: EXPERIMENTAL
Intervention: Isometric contraction (10-min static plantar flexion of one calf at 200 N)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Passive calf muscle stretch (10 min at the same load of 200 N)
Number of subjects: 7
Study: 2650897

Group type: EXPERIMENTAL
Intervention: 15 mg.kg‐1 rectal methohexitone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 20 mg.kg‐1 rectal methohexitone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 25 mg.kg‐1 rectal methohexitone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 30 mg.kg‐1 rectal methohexitone
Number of subjects: 60

Group type: COMPARATOR
Intervention: 15 mg.kg‐1 and 20 mg.kg‐1 rectal methohexitone
Number of subjects: 60
Study: 1096630

Group type: EXPERIMENTAL
Intervention: 1% tetracycline ointment
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: 1% rifampicin ointment
Number of subjects: 234

Group type: COMPARATOR
Intervention: 5% boric acid ointment
Number of subjects: 234
Study: 31722055

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon
Number of subjects: 136

Group type: COMPARATOR
Intervention: Plain angioplasty balloon
Number of subjects: 136
Study: 29321180

Group type: EXPERIMENTAL
Intervention: Low-dose hydrocortisone
Number of subjects: 379

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 379
Study: 28027761

Group type: EXPERIMENTAL
Intervention: New imaging technology (after upgrade)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Precursor technology (before upgrade)
Number of subjects: 108
Study: 25732875

Group type: EXPERIMENTAL
Intervention: Alcohol (n=31)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (n=29)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control (n=25)
Number of subjects: 85
Study: 22517125

Group type: EXPERIMENTAL
Intervention: Trocar guided polypropylene mesh kit repair
Number of subjects: 353
Study: 20946751

Group type: EXPERIMENTAL
Intervention: Wine
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Beer
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Distilled spirits
Number of subjects: 498
Study: 18547287

Group type: EXPERIMENTAL
Intervention: Oral prednisone for 2 weeks and intranasal budesonide for 12 weeks (treatment group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 32
Study: 16299871

Group type: EXPERIMENTAL
Intervention: 0.1 IU/kg per day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 0.2 IU/kg per day
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no treatment for 1 year after 2 years of treatment)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both doses
Number of subjects: 35
Study: 12006794

Group type: EXPERIMENTAL
Intervention: Midazolam (5 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Lorazepam (4 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.5 mg) administered to seven benzodiazepine-treated patients
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nonpremedicated controls
Number of subjects: 45
Study: 10337606

Group type: EXPERIMENTAL
Intervention: Multiple chemical sensitivity (MCS) group
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Asthma group
Number of subjects: 63

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: MCS group
Number of subjects: 63
Study: 7473011

Group type: EXPERIMENTAL
Intervention: Tetracycline HCl (TTC) 10 mg/ml for 1 minute
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetracycline HCl (TTC) 10 mg/ml for 4 minutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetracycline HCl (TTC) 100 mg/ml for 1 minute
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetracycline HCl (TTC) 100 mg/ml for 4 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (sterile saline for 1 minute)
Number of subjects: 0
Study: 1955166

Group type: EXPERIMENTAL
Intervention: Lactulose given by mouth during gastric phases I, II, III
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Lactulose infused duodenally during duodenal phases I, II, III
Number of subjects: 6
Study: 6161804

Group type: EXPERIMENTAL
Intervention: Oral prophylaxis with broad spectrum tetracycline (Group B)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Infusion prophylaxis (Group C)
Number of subjects: 118

Group type: COMPARATOR
Intervention: No treatment (Group A)
Number of subjects: 118
Study: 29981096

Group type: EXPERIMENTAL
Intervention: Vitamin supplements
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Non-smoking, higher education, higher income, food security, increased body mass index
Number of subjects: 249

Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 249
Study: 27416975

Group type: EXPERIMENTAL
Intervention: Bacillus Calmette-Guérin maintenance therapy (intravesical instillations once a week for 3 weeks at 3, 6, 12 and 18 months after induction)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Non-maintenance group (bacillus Calmette-Guérin induction therapy only)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Bacillus Calmette-Guérin maintenance therapy
Number of subjects: 95
Study: 24399101

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Cognitive training (CT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control
Number of subjects: 104
Study: 22170807

Group type: EXPERIMENTAL
Intervention: Intranasal fluticasone furoate
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 19875277

Group type: EXPERIMENTAL
Intervention: Transdermal tulobuterol (2mg) combined with inhaled tiotropium (18microg)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Inhaled tiotropium (18microg)
Number of subjects: 103
Study: 18412932

Group type: EXPERIMENTAL
Intervention: MXR 1500 mg once daily after dinner
Number of subjects: 150

Group type: COMPARATOR
Intervention: MIR 500 mg thrice daily after meals
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: MXR or MIR
Number of subjects: 150
Study: 16319559

Group type: EXPERIMENTAL
Intervention: Online programme
Number of subjects: 15

Group type: COMPARATOR
Intervention: Computer‐assisted programme
Number of subjects: 15

Group type: COMPARATOR
Intervention: Therapist‐administered programme
Number of subjects: 15